EP3354276

MERITAGE PHARMA
Application Number
EP17210162A
Filing Date
Nov 12, 2008
Status
Revoked
Apr 15, 2022
Grant Date
Jan 1, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3354276B1 was granted on Jan 1, 2020 by Meritage Pharma . The latest application status of the patent is - Revoked.

AI Generated Summary New

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

AECHTEROct 1, 2020ADMISSIBLE
DR FALK PHARMASep 23, 2020ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents